EPISODE · Jan 18, 2024 · 45 MIN
Biden’s Drug Pricing March-in Proposal
from Votes & Verdicts · host Bloomberg
The Biden administration proposes to expand the march-in framework to include price as a factor in determining that a drug isn’t accessible to the public. March-in rights allow the US government to license to another entity patents covering inventions developed with the help of taxpayer dollars and could apply to a handful of drugs. Dr. Aaron Kesselheim of the Harvard Medical School joins Bloomberg Intelligence Analysts Duane Wright and Tish Walker on this episode of the Votes and Verdicts podcast to discuss why price should be a factor for march-in rights and the implications for federally supported research and development.See omnystudio.com/listener for privacy information.
NOW PLAYING
Biden’s Drug Pricing March-in Proposal
No transcript for this episode yet
Similar Episodes
Jul 8, 2026 ·29m
Jul 6, 2026 ·84m
Jul 4, 2026 ·23m
Jul 4, 2026 ·89m
Jun 27, 2026 ·20m